K P Ratzmann

The Efficacy and Safety of Miglitol Therapy Compared With Glibenclamide in Patients With NIDDM Inadequately Controlled by Diet Alone

P Segal, PU Feig, G. Schernthaner et al. · Diabetes Care · 1997 · 114 citations

Urinary enzymes and low-molecular-mass proteins as indicators of diabetic nephropathy.

Klaus Jung, M Pergande, E Schimke et al. · Clinical Chemistry · 1988 · 67 citations · Full text

Group A, Urinary Enzymes, Excretion Rates +17

Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes

K P Ratzmann, B. Schulz, P Heinke et al. · Diabetologia · 1984 · 30 citations · Full text

Obesity, Metabolic Syndrome, Type 1 +6

Diurnal Rhythm of Insulin Sensitivity in Subjects with Normal and Impaired Glucose Tolerance¹)

B. Schulz, K P Ratzmann, G. Albrecht et al. · Experimental and Clinical Endocrinology & Diabetes · 2009 · 19 citations

Obesity, Metabolic Syndrome, Body Composition +18

Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance

K P Ratzmann, W. Besch, Sabine Witt et al. · Diabetologia · 1981 · 15 citations · Full text

Obesity, Metabolic Syndrome, Insulin Resistance +14